DADina Abugaber

Dina Abugaber

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Dina Abugaber has a total of 33 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Knowledge, Attitudes, and Practices Regarding Intravenous Fluids Among Physicians in the West Bank of Palestine: A Cross‐Sectional Study

    by Mamoun Swaileh, Razan Rabi, Dina Abugaber, Yusuf B. Dawabsheh, Murad A. M. Karajeh, Halla Albada, Ziad Radad, Sa'ED H. Zyoud, Moutaz W. Sweileh

    Background and Aims: Inappropriate use of intravenous (IV) fluids is associated with increased morbidity. Despite their routine use in hospitalized patients, physicians' knowledge, attitudes, and practices (KAP) regarding IV fluids remain inadequately investigated. This study assessed physicians' KAP in the West Bank, Palestine. Methods: A cross‐sectional online survey targeted physicians caring for hospitalized adult patients in West Bank hospitals. A questionnaire assessed demographic and professional characteristics, knowledge, attitudes, practices, and perceived barriers regarding IV fluids. Knowledge scores were converted into percentages and summarized using medians/interquartile ranges (IQR). Comparison of knowledge scores across physician subgroups was performed using the Mann–Whitney U test and the Kruskal–Wallis test, with Dunn's post hoc test and a Holm adjustment where appropriate. Attitudes, practices, and perceived barriers were presented as frequencies and percentages. Results: Of 256 participants (median age = 28 years, IQR 25–33), there were 173 (67.6%) males and 72 (28.1%) reported receiving formal IV fluids training during the previous 2 years. Residents and fellows comprised 101 (39.5%). The median knowledge score was 57.7% (IQR 35.7). The highest correct response in the knowledge section ( n = 223, 87.1%) was observed for identifying hyperchloremic metabolic acidosis as a complication of 0.9% saline, while the lowest correct response ( n = 67, 26.2%) was observed for identifying IV fluids not recommended for routine use. Knowledge scores differed significantly by departmental affiliation ( P < 0.001) and professional position status ( P = 0.03). Regarding attitudes, 116 (45%) agreed/strongly agreed that balanced crystalloids should be preferred over 0.9% saline in most ICU patients. In practice, 140 (54.7%) reported using 0.9% saline as the first‐line fluid in their practice. The most cited barrier was the absence of institutional guidelines ( n = 157, 61.3%). Conclusion: Physicians demonstrated average knowledge, suboptimal practices, and limited agreement with evidence‐based attitudes toward IV fluid therapy. Educational interventions and hospital protocols are needed to help improve KAP.

  • Open Access

    Non-thyroidal Illness Syndrome and Clinical Outcomes in Critically Ill ICU Patients: A Prospective Cohort Study

    by Razan Rabi, Imad Ismail, Mays Safa, Anas Odeh, Khair Marmash, Dina Abugaber

    Background Non-thyroidal illness syndrome (NTIS) is a common condition in critically ill patients, yet its prognostic value remains unclear. This study aimed to assess the incidence of NTIS among critically ill patients and evaluate its association with clinical outcomes and mortality. Methods A prospective cohort study was conducted in a tertiary hospital between 2019 and 2025. Adult intensive care unit (ICU) patients without known thyroid disease were included. Thyroid function tests, including thyroid-stimulating hormone (TSH), free thyroxine (FT4), and free triiodothyronine (FT3), were measured within 24 hours of admission. Clinical data, comorbidities, and outcomes were recorded. Patients were classified as having low FT3 (<3.0 nmol/L) or normal FT3 (≥3.0 nmol/L). Logistic regression and receiver operating characteristic (ROC) analysis were used to evaluate the prognostic performance of thyroid hormones, with survival used as the reference outcome. Results Among 180 patients (mean age = 57.7 ± 18 years; 111/180 (62%) male), 93/180 (52%) had NTIS. Patients with low FT3 were older and had higher rates of diabetes, cardiovascular, and pulmonary diseases (p < 0.05). They more frequently developed shock, respiratory failure, and required mechanical ventilation. ICU mortality was significantly higher among the low FT3 group (37/93 (43%) vs. 7/85 (7.5%), p < 0.001). After adjustment for age, comorbidities, and illness severity, both low FT3 (OR = 0.23, 95% CI = 0.07-0.79; p = 0.007) and low FT4 (OR = 0.80, 95% CI = 0.65-0.99; p = 0.03) remained independently associated with mortality, whereas TSH showed no significant association. ROC analysis demonstrated that FT3 had the strongest association with survival (area under the curve = 0.208, p < 0.001), reflecting an inverse relationship when survival was used as the reference outcome. Conclusion NTIS is highly prevalent in critically ill patients and is associated with increased mortality and adverse outcomes. Low FT3, in particular, is associated with disease severity and may serve as a prognostic marker in the ICU; however, these findings reflect association rather than causation.


  • Open Access

    Central line-associated bloodstream infections (CLABSI) in critical care: understanding incidence, and risk factors in Palestine

    by Sameer Alomari, Mohammad Yahya, Nadeem Alabadlah, Khader Thiab, Walid Basha, Haneen Dhaidel, Razan Rabi, Dina Abugaber, Ahmad Enaya

    Central line-associated bloodstream infections (CLABSIs) represent a major source of morbidity and mortality, particularly in developing countries. Central venous catheters (CVCs) are an essential part of managing critically ill patients. This study seeks to describe the epidemiology of central line-associated bloodstream infections CLABSI among ICU patients in Palestine and to identify the specific organism involved. This retrospective descriptive study included 323 ICU patients with 490 central venous catheters. The electronic medical records were reviewed to identify patients with CLABSIs hospitalized from January 2018 through December 2021. Comparative analysis was conducted to assess associations between various variables and the incidence of CLABSI. A total of 19 CLABSI episodes in 323 patients yielded an incidence of CLABSI of approximately 5.9%, with a rate of 8.91 per 1,000 device days. CLABSI patients had significantly more CVC utilization ratio and insertions compared to non-CLABSI patients. No significant differences were observed in age, gender, or overall mortality. The most predominant bacteria was Acinetobacter baumannii (21%). This study highlights the importance of minimizing CVC use and limiting the number of insertions to reduce CLABSI risk. Effective management strategies should focus on reducing CVC duration and frequency.


  • Open Access

    Catheter-associated urinary tract infections in critical care: Understanding incidence, risk factors, and pathogenic causes in Palestine

    by Razan Rabi, Ahmad Enaya, Dana Mufeed Jomaa, Mo’tasem Z. Dweekat, Shahd Raddad, Zain Tareq Saqfalhait, Dina Abu-Gaber

    Catheter-associated urinary tract infections (CAUTI) are the most common secondary cause of bloodstream infection. CAUTI is particularly prevalent in critical care departments and developing countries, where the duration of catheterization remains the most significant risk factor. This study focused on the characteristics, risk factors, and outcomes of CAUTI patients in a tertiary care hospital setting. It also provides the incidence rate of CAUTI in an ICU setting in Palestine. The study adopted a retrospective observational design at a tertiary care hospital in Palestine. The data were collected from patient records as well as from nursing flow charts. Variables are reported as frequencies, percentages and means + standard deviations. Independent t-tests was used for numerical variables, while Pearson’s chi-square or Fisher’s exact test were used for categorical variables. Multivariate analysis was performed to adjust for confounders using binary logistic regression. Mortality risk factors were assessed using the proportional Cox regression model. Of the 377 patients included in the study, 33 (9%) developed CAUTI. Among CAUTI patients, 75% had Candida species isolated, with non-albicans Candida predominating (72%) fungal isolates. On the other hand, 25% of the patients had bacterial isolates in their urine, with a predominance of Escherichia coli growing in 36% of bacterial cultures. Multivariate regression analysis revealed that female gender, longer catheterization days, and corticosteroid use were associated with an increased risk of CAUTI. On the other hand, developing CAUTI, having a malignant disease, developing kidney injury, and developing shock were associated with increased mortality. This study highlighted the emerging presence of fungal and resistant bacterial CAUTI. It also emphasized that the risk of CAUTI was associated with a longer duration of urinary catheterization. The findings of this study may help formulate antimicrobial management and stewardship plans as well as emphasize the risk of urinary catheterizations.


  • Open Access

    Takotsubo Cardiomyopathy: Patients Characteristics, Mortality, and Clinical Significance of Left Ventricular Outflow Tract Gradient, Retrospective Study

    by Yunis Daralammouri, Hamza Hamayel, Dina Abugaber, Sari Nabulsi

    Background. Takotsubo cardiomyopathy (TC) is a reversible left ventricular systolic dysfunction with apical ballooning. Left ventricular outflow tract (LVOT) obstruction may develop in these cases due to hyperdynamic state of the left ventricle. Limited data are available on the prevalence of LVOT gradient in TC and its association with patient outcomes and mortality. Methods. Data were collected retrospectively for patients diagnosed with TC in a single tertiary center, demographic information, blood analysis results, and imaging finding including ejection fraction, and LVOT gradient was obtained from medical records. Additionally, medical treatment and outcome during hospitalization were extracted. Follow‐up was conducted through cardiology clinic or phone contact. Result. A total of 59 patients diagnosed with TC were reviewed during hospitalization, and 40 patients were followed up after discharge by phone contact and cardiology clinic. Most patients were female (91.5%), and nonsignificant coronary artery disease was present in 16.9% of patients. Approximately two‐third of the patients had a reduced ejection fraction on admission, and only two patients (5.4%) continued to have reduced ejection fraction on echocardiography follow‐up within a period of 2–14 days. LVOT gradient was present in 17 patients (28.5%); patients with preserved ejection fraction had a higher probability of having an LVOT gradient. However, there was no association between LVOT gradient and shock or mortality. Four patients (6.7%) experienced 30‐day mortality, while all‐cause mortality was reported in eight patients (13.5%) over the follow‐up period (mean (±SD) 20.8 months ± 16.2). Conclusion. LVOT obstruction may occur in TC patients; it has no correlation with shock or mortality. However, determining whether there is a gradient is important for deciding on specific treatment approach.

  • Open Access

    Comprehensive Assessment of Colistin Induced Nephrotoxicity: Incidence, Risk Factors and Time Course

    by Razan Rabi, Ahmad Enaya, Mamoun W Sweileh, Banan M Aiesh, Ashraqat Namrouti, Zakaria I Hamdan, Dina Abugaber, Zaher Nazzal

    Purpose: In recent years, the emergence of multidrug-resistant (MDR) microorganisms had caused the resurgence of colistin use after it was previously abandoned due to its side effects, nephrotoxicity in particular. However, the specific incidence of colistin-induced nephrotoxicity varies in reports with different populations. This study aims to assess the incidence of colistin-associated nephrotoxicity and the associated risk factors. Patients and Methods: This study was on 178 patients who received colistin for more than 48 hours during the years 2019– 2022, who were followed up for 14 days after the initiation of colistin, and demographic and clinical data were gained from medical reports. Logistic regression was used to assess the relationship between nephrotoxicity and study variables. Results: The incidence of nephrotoxicity was 44.9% (95% confidence interval (CI); 37% to 53%), and the overall mortality was 33%, with a significantly higher level among patients with nephrotoxicity. The significant risk factors for nephrotoxicity after adjustment were; higher weights (OR = 1.1, 95% CI; 0.03– 1.2), P-value: 0.006, and the combination with carbapenem showed a significant protective effect (OR = 0.09, 95% CI; 0.01– 0.8), P-value: 0.03. The severity, according to KDIGO classification, was stage 1 (47%), stage 2 (21%), and stage 3 (31%). Higher stages had earlier onset acute kidney injury, a lower percentage of returning to baseline, and exposure to a higher colistin dose. Conclusion: Colistin-induced nephrotoxicity was a frequent issue associated with higher weights, mitigated by the combination with carbapenems. While higher colistin dosages, and earlier onset AKI, were linked to the progression to higher AKI stages and the need for dialysis.